Eric Rougemond

Eric Rougemond is from France. In Eric's previous role as a Chief Executive Officer at VEDALAB, Eric worked in Francia. Prior to joining VEDALAB, Eric was a Chief Executive Officer at Laboratoire Aguettant (Aguettant Group) and held the position of Chief Executive Officer at Lyon et périphérie. Prior to that, Eric was a Chief Executive Officer at PROMISE Advanced Proteomics (Aguettant Group) from Feb 2013 to Oct 2025. Eric started working as Chief Executive Officer at PX'Therapeutics (Aguettant Group) in Feb 2013. From Apr 2007 to Feb 2013, Eric was Vice President France, Benelux, Nordic Countries, Southern Eu, International at EUSA Pharma. Prior to that, Eric was a Medical Director at OPi (Orphan Pharmaceutical International) from Feb 2005 to Apr 2007. Eric started working as Medical Director at Merck Group in Nov 1999.